An update of genetic basis of PCOS pathogenesis
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder that affects 5-20% of reproductive age women. PCOS clinical symptoms include hirsutism, menstrual dysfunction, infertility, obesity and metabolic syndrome. There is a wide heterogeneity in clinical manifestations and metabolic complications. The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen secretion, partial folliculogenesis arrest, insulin resistance and neuroendocrine axis dysfunction. A definitive etiology remains to be elucidated, but PCOS has a strong heritable component indicated by familial clustering and twin studies. Genome Wide Association Studies (GWAS) have identified several new risk loci and candidate genes for PCOS. Despite these findings, the association studies have explained less than 10% of heritability. Therefore, we could speculate that different phenotypes and subphenotypes are caused by rare private genetic variants. Modern genetic studies, such as whole exome and genome sequencing, will help to clarify the contribution of these rare genetic variants on different PCOS phenotypes. Arch Endocrinol Metab. 2018;62(3):352-61.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A large number of genetic and genome-wide association studies (GWAS) have identified common gene loci associated with PCOS phenotypes in different ethnic populations [29,30,31].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This adaptive protective mechanism can be pathway-specific during periods of growth, such as pregnancy, lactation and adolescence, so that only the metabolic signaling (PI-3K) is inhibited and not the mitogenic pathway (MAPK), which may even be up-regulated [30,65,160].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Defects in metabolic actions of insulin occur in muscle and adipose tissues, but mitogenic and steroidogenic actions of insulin in ovaries are preserved (28).”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Research works printed but not linked: 1
- 3. JK Z. Diagnostic criteria of polycystic ovary syndrome; towards a rational approach. In: Dunaif A, ditor. Polycystic Ovary Syndrome ed. Boston, MA: Blackwell Scientific; 1992.
Cited by
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 354
Hiam, D., Moreno-Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L. J., & Gibson-Helm, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 126
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
“The risk genes regulate a variety of reproductive and metabolic function, including gonadotropin secretion (FSHB), gonadotropin action and ovarian function (LHCGR, FSHR, DENND1A, RAB5/SUOX, HMGA2, C9orf3, YAP1, TOX3, RAD50, FBN3, and AMH) and metabolic function (THADA, GATA/NEIL2, ERBB4, SUMOP11, INSR, and KRR1) [21,2…”
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Parker, J., O’Brien, C., Hawrelak, J., & Gersh, F. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031336 · Cited by 114
“This adaptive protective mechanism can be pathway-specific during periods of growth, such as pregnancy, lactation and adolescence, so that only the metabolic signaling (PI-3K) is inhibited and not the mitogenic pathway (MAPK), which may even be up-regulated [30,65,160].”
BackgroundPolycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
parker, J., O'Brien, C., Hawrelak, J., & Gersh, F. (2021) · doi:10.20944/preprints202112.0088.v1 · Cited by 113
Metabolomic Insight into Polycystic Ovary Syndrome—An Overview
Rajska, A., Buszewska-Forajta, M., Rachoń, D., & Markuszewski, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144853 · Cited by 102
Yang, Y., Zhou, W., Wu, S., Tang, W., Wang, Z., Zhou, Z., Li, Z.-W., Huang, Q.-F., He, Y., & Zhou, H. (2021) · Endocrinology · doi:10.1210/endocr/bqab118 · Cited by 113
Chang, K.-J., Chen, J.-H., & Chen, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169037 · Cited by 108
Mitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology
Siemers, K. M., Klein, A. K., & Baack, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713123 · Cited by 91
PCOS and nutritional approaches: Differences between lean and obese phenotype
Barrea, L., Frias-Toral, E., Verde, L., Ceriani, F., Cucalón, G., Garcia-Velasquez, E., Moretti, D., Savastano, S., Colao, A., & Muscogiuri, G. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100123 · Cited by 86
Yu, L., Liu, M., Wang, Z., Liu, T., Liu, S., Wang, B., Pan, B., Dong, X., & Guo, W. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00749-6 · Cited by 79
Current concepts of polycystic ovary syndrome pathogenesis
Rosenfield, R. L. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000945 · Cited by 77
Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium
Xue, Z., Li, J., Feng, J., Han, H., Zhao, J., Zhang, J., Han, Y., Wu, X., & Zhang, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.788772 · Cited by 71
Understanding long COVID: nosology, social attitudes and stigma
Byrne, E. A. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.012 · Cited by 61
Zhang, H., Wang, X., Xu, J., Zhu, Y., Chen, X., & Hu, Y. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103083 · Cited by 46
He, Y., Tian, J., Blizzard, L., Oddy, W. H., Dwyer, T., Bazzano, L. A., Hickey, M., Harville, E. W., & Venn, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa069 · Cited by 39
Polycystic ovary syndrome and obesity: clinical aspects and nutritional management
FRIAS-TORAL, E., GARCIA-VELASQUEZ, E., de los ANGELES CARIGNANO, M., RODRIGUEZ-VEINTIMILLA, D., ALVARADO-AGUILERA, I., & BAUTISTA-LITARDO, N. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03349-6 · Cited by 40
Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome
Evliyaoğlu, O., Imöhl, M., Weiskirchen, R., & van Helden, J. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1059 · Cited by 36
Żeber‐Lubecka, N., & Hennig, E. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606620 · Cited by 39
Impact of junk food on obesity and polycystic ovarian syndrome: Mechanisms and management strategies
Begum, R. F., Ankul Singh, S., & Mohan, S. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100495 · Cited by 43
Actkins, K. V., Singh, K., Hucks, D., Velez Edwards, D. R., Aldrich, M., Cha, J., Wellons, M., & Davis, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa675 · Cited by 27
Rad, H. M., Mowla, S. J., Ramazanali, F., & Valojerdi, M. R. (2022) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.05.013 · Cited by 26
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 30
Mallya, P., & Lewis, S. A. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01660-z · Cited by 29
Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
Li, N., Yang, C., Xie, H., Liu, Y., & Liao, Y. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5561980 · Cited by 28
Transgenerational Inheritance of Reproductive and Metabolic Phenotypes in PCOS Rats
Zhang, H., Yi, M., Li, D., Li, R., Zhao, Y., & Qiao, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00144 · Cited by 23
Mazloomi, S., Farimani, M. S., Tayebinia, H., Karimi, J., Amiri, I., Abbasi, E., & Khodadadi, I. (2022) · Journal of Reproduction & Infertility · doi:10.18502/jri.v23i3.10005 · Cited by 20
Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
Petrillo, T., Semprini, E., Tomatis, V., Arnesano, M., Ambrosetti, F., Battipaglia, C., Sponzilli, A., Ricciardiello, F., Genazzani, A. R., & Genazzani, A. D. (2022) · Biomedicines · doi:10.3390/biomedicines10081924 · Cited by 23
Kisspeptin Influence on Polycystic Ovary Syndrome—a Mini Review
Araújo, B. S., Baracat, M. C. P., Simões, R. S., Nuñes, C. D. O., Maciel, G. A. R., Løbo, R. A., Soares, J. M., & Baracat, E. C. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00085-6 · Cited by 23
Bishop, C. V., Takahashi, D. L., Mishler, E., Slayden, O. D., Roberts, C. T., Hennebold, J. D., & True, C. A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa321 · Cited by 21
Liu, M., Hummitzsch, K., Hartanti, M. D., Rosario, R., Bastian, N. A., Hatzirodos, N., Bonner, W. M., Irving‐Rodgers, H. F., Laven, J. S. E., Anderson, R. A., et al. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa119 · Cited by 20
Ho, C.-H., Chang, C.-M., Li, H., Shen, H.-Y., Lieu, F.-K., & Wang, P. S.-G. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.09.011 · Cited by 24
Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches
Amuzescu, A., Tampa, M. Ş., Matei, C., & Georgescu, S. R. (2024) · Cosmetics · doi:10.3390/cosmetics11030074 · Cited by 22
Artini, P. G., Obino, M. E. R., Micelli, E., Malacarne, E., Vacca, C., Papini, F., & Cela, V. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1737007 · Cited by 18
Artimani, T., & Najafi, R. (2020) · Cell Biology International · doi:10.1002/cbin.11367 · Cited by 19
Falahatian, S., Haddad, R., & Pakravan, N. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-021-00926-6 · Cited by 17
Food, nutrition, and fertility: from soil to fork
Maitin‐Shepard, M., Werner, E. F., Feig, L. A., Chavarro, J. E., Mumford, S. L., Wylie, B. J., Rando, O. J., Gaskins, A. J., Sakkas, D., Arora, M., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.12.005 · Cited by 16
Li, X., Fang, Z., Yang, X., Pan, H., Zhang, C., Li, X., Bai, Y., & Wang, F. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14725 · Cited by 17
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ilias, Ι., Goulas, S., & Zabulienė, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i12.2711 · Cited by 16
da Rocha, T. J. C. M., Crespo, R. P., Yance, V. D. R. V., Hayashida, S. A. Y., Baracat, E. C., Carvalho, F. M., Domenice, S., Mendonca, B. B., & Gomes, L. G. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00405 · Cited by 15
Self-citationZhang, F.-F., Zhang, Q., Wang, Y.-L., Wang, F., Hardiman, P., & Qu, F. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.01.018 · Cited by 14
Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes
Pölönen, J., Pinola, P., Ronkainen, J., Blakemore, A. I. F., Buxton, J. L., Tapanainen, J. S., Franks, S., Piltonen, T., Sebert, S. P., & Morin-Papunen, L. C. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0462 · Cited by 16
Saleem, H. M., Al‐Hetty, H. R. A. K., Ahmed, A. T., Awad, M. M., Al-Ani, M. Q., Al-Darraji, M. N., Salman, D. A., & Ali, L. H. (2025) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106947 · Cited by 14
A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome
Chelegahi, A. M., Ebrahimi, S. O., Reiisi, S., & Nezamnia, M. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.23193 · Cited by 13
Daghestani, M. H., Daghestani, M. H., Daghistani, M., Ambreen, K., Almuammar, M., Neghery, L. A., & Warsy, A. S. (2020) · British Journal of Biomedical Science · doi:10.1080/09674845.2020.1726662 · Cited by 16
Wiweko, B., Handayani, L. K., Harzif, A. K., Pratama, G., Muharam, R., Hestiantoro, A., & Sumapraja, K. (2020) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v18i3.6716 · Cited by 12
Yu, J., Ding, C., Guan, S., & Wang, C. (2019) · Bioscience Reports · doi:10.1042/bsr20190292 · Cited by 12
Krysiak, R. G., Szkróbka, W., & Okopień, B. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00135-w · Cited by 11
Porth, R., Oelerich, K., & Sivanandy, M. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041056 · Cited by 14
Lee, Y. Z., Cheng, S.-H., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168706 · Cited by 11
Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
Gangitano, E., Scannapieco, F., Lubrano, C., & Gnessi, L. (2024) · Livers · doi:10.3390/livers4040038 · Cited by 11
Park, S., Liu, M., & Zhang, T. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0969-1872 · Cited by 12
Polycystic ovary syndrome and immune deregulation: what do hormones want to say?
Johnson, B. S., & Laloraya, M. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00058 · Cited by 13
Zhang, F., Tang, C., Wang, J., Lin, T., Ge, W., He, C., Yang, C., & Zuo, Z. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123723 · Cited by 10
Al‐Awadi, A. M., Babi, A., Finan, R. R., Atageldiyeva, K. K., Shaimardanova, M., Mustafa, F. E., Mahmood, N., Aimagambetova, G. N., & Almawi, W. Y. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.06.009 · Cited by 10
Richard, S. L., Renn, B. N., Tran, D.-M. T., Kim, J., & Du, F. (2024) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad071 · Cited by 9
Epigenetic Marks in Polycystic Ovary Syndrome
Motta, A. B. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191003154548 · Cited by 9
Zheng, S., Chen, H., Yang, H., Zheng, X., Fu, T., Qiu, X., & Wang, M. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1229723 · Cited by 8
Zhang, J., Xu, W., Li, S., Zhang, J., Shang, Y., & Gui, J. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.017 · Cited by 8
Naserpoor, L., Jannatifar, R., Roshanaei, K., Khoshandam, M., & Kalhor, N. (2022) · PubMed Central · doi:10.22074/ijfs.2021.524795.1090 · Cited by 8
Association of FSHR and DENND1A polymorphisms with polycystic ovary syndrome: a meta-analysis
Larsen, C. B., Kúdela, E., & Biringer, K. (2022) · JBRA · doi:10.5935/1518-0557.20220043 · Cited by 8
Role of circular RNA/miRNA axes in the pathophysiology of polycystic ovary syndrome
Ahmadi, M., Fathi, M., Malmir, A., & Ghafouri‐Fard, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09376-x · Cited by 8
Shan, D., Han, J., Cai, Y., Zou, L., Xu, L., & Shen, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab640 · Cited by 9
Alarcón-Granados, M. C., Moreno-Ortíz, H., Rondón‐Lagos, M., Villalba, G. E. C., & Forero‐Castro, M. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.102202 · Cited by 8
Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets
Shirasath, K. R., Ahmed, N. Z., Kumar, P., Alam, S., Karwasra, R., Goyal, S. N., & Agrawal, Y. O. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156245 · Cited by 7
Zhang, J., Mai, Q., & Zhou, C. (2024) · American Journal of Translational Research · doi:10.62347/kews9270 · Cited by 8
Padder, K. A., Yousuf, M., Jahan, N., Yousuf, S. D., & Ganie, M. A. (2024) · Endocrine · doi:10.1007/s12020-024-04137-z · Cited by 6
He, Y., wang, C., Sun, Q., Liu, R., Wang, C., Zhou, R., Freitas, R., & Zhang, Y. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.138173 · Cited by 7
Al‐Awadi, A. M., Saldhana, F. L., Bauyrzhanova, Z., Nemr, R., Mahmood, N., & Almawi, W. Y. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13731 · Cited by 6
Żeber‐Lubecka, N., Suchta, K., Kulecka, M., Kluska, A., Piątkowska, M., Dąbrowski, M. J., Jankowska, K. K., Grymowicz, M., Smolarczyk, R., & Hennig, E. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193293 · Cited by 7
Association of prolactin and insulin with obesity in women with polycystic ovarian syndrome
Lavanya, K., Palaniappan, N., Vinodhini, V. M., Mahesh Kumar, K., & Silambanan, S. (2022) · Biomedicine · doi:10.51248/.v42i6.1613 · Cited by 7
Alarcón-Granados, M. C., Villalba, G. E. C., & Forero‐Castro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179212 · Cited by 5
Nawaito, S. A., Esmael, M., Souchkova, O., Cardinal, T., Bernas, G., Bergeron, K., Gayda, F., Bergeron, F., Bouchard, M., Zhou, X., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202401718rr · Cited by 5
Morales‐Ledesma, L., Trujillo, A., Ramírez, M. I., Rosas, G., & Linares, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118792 · Cited by 5
Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome
Qiao, G., Xing, J., Luo, X., Zhang, C., & Yi, J. (2022) · Endocrine · doi:10.1007/s12020-022-03181-x · Cited by 5
Akbari, A., Aboutorabi, R., Kazemi, M., Borzouie, Z., Feizi, A., Naghshineh, E., & Mostafavi, F. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_111_21 · Cited by 5
Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype
Cai, J., Luo, X., Wang, Z., Chen, Z., Huang, D., Cao, H., Chen, J., & Wu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29879 · Cited by 4
Zhang, J., Li, Y., Gong, A., & Wang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1442483 · Cited by 4
Metabolic and hormonal profiling in polycystic ovarian syndrome: insights into INSR gene variations
Rasheed, R. A., Rasheed, P. H., & Ali, A. M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09924-5 · Cited by 4
Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
Бурка, О. А., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.46.39-45 · Cited by 6
Diseases of the genitourinary system
Nesterova, A. P., Климов, Е. А., Zharkova, M., Sozin, S., Соболев, В. В., Ivanikova, N. V., Shkrob, M., & Yuryev, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817086-1.00013-0 · Cited by 4
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
Манжалій, Е., Татарчук, Т. Ф., Tutchenko, T. М., Косей, Н. В., & Mnevets, R. O. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.70.40-45 · Cited by 3
Lin, Q., Zhang, H., Zhao, J.-H., & Wang, Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89246 · Cited by 3
Hu, L., Liu, Y., Dong, P., & Ye, P. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2190808 · Cited by 3
Lubis, H. P., Siregar, M. F. G., Adenin, I., Halim, B., Siregar, H. S., & Prabudi, M. O. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4182 · Cited by 3
Pratiwi, D., Harimawan, A. I. W., Weta, I. W., Sumartini, N. K., Awan, S. A., & Sutadarma, I. W. G. (2026) · Universa Medicina · doi:10.18051/univmed.2026.v45.125-134 · Cited by 2
Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
Markantes, G. Κ., Panagodimou, E., Koika, V., Mamali, I., Kaponis, A. I., Adonakis, G. L., & Georgopoulos, N. A. (2024) · Biomedicines · doi:10.3390/biomedicines12020334 · Cited by 2
Extracellular fluid miRNAs in PCOS
Hadi, S., Khoshraftar, S. H., Darabi, A. H. K., Soleimani, A., & Nejabati, H. R. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120404 · Cited by 2
DENND1A and THADA Gene Polymorphism Among Iraqi Women With Polycystic Ovary Syndrome
Alizzi, F. J., Kokaz, H. T., & Al-Mayah, Q. S. (2019) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2020.43 · Cited by 2
Prati, A., Genazzani, A. R., & Genazzani, A. D. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_5 · Cited by 3
Survey based on classification of PCOS using gene expression
Poorani, B., & Kalaivani, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns3.9225 · Cited by 2
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 3
Genetic basis of metabolism and inflammation in PCOS
Pang, Y., Zhao, Y., & Qiao, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00002-2 · Cited by 3
Acne Management in Polycystic Ovary SyndromePreprint
Dagash, R., Daghash, A., & Abu-Taha, M. I. (2020) · doi:10.22541/au.158758005.54259309 · Cited by 2
Polycystic ovary syndrome (PCOS) - risk factor, diagnostic and current treatment
Wójcik, J., Obuchowska, A., Ozga, A., Standyło, A., Obuchowska, K., & Piotrowska, P. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.09.067 · Cited by 1
Ben-Issa, N. A.-H., Abofaed, M., Alqeeyadi, H., Alshahrani, M., & Alsherif, E. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2471012 · Cited by 3
Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
Jaroń, A., Wiklińska, A., Jastrzębska, K., Witkowska, M., Skotnicka, J., Błaszczak, K., Turek, M., Wojciechowska, K., Borkowski, A., & Sawicki, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.20.53831 · Cited by 2
Upadhyay, S., Mazumder, A., & Das, S. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128382284250822045319 · Cited by 1
The Plasma Glycome Differences Between Women with PCOS and Healthy Controls
Holman, M., Li, S. J., Ahern, M. M., Ruhaak, L. R., Karakas, S., & Krishnan, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052350 · Cited by 1
Metadata
- Authors
- Crespo, R. P., Bachega, T. A. S. S., Mendonça, B. B., & Gomes, L. G.
- Affiliations
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- ORCID
- Gomes, Larissa G.
- Venue
- Archives of Endocrinology and Metabolism
- Published
- 2018-06
- Volume
- 62
- Issue
- 3
- Pages
- 352-361
- ISSN
- 2359-3997 (ISSN-L)
- 2359-4292
- PMC
- PMC10118782
- OpenAlex
- W2810280311
- Cited by
- 138
- References
- 65
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 27 · 2023: 19 · 2022: 22 · 2021: 18 · 2020: 24 · 2019: 13
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Archives of Endocrinology and Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, PCOS pathogenesis, genetic basis, heritability, genome-wide association study, candidate genes, rare variants, hyperandrogenism, insulin resistance, folliculogenesis, neuroendocrine dysfunction, PCOS phenotypes, twin studies, familial aggregation
- MeSH terms
- Female, Humans, Phenotype, Polycystic Ovary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.